Elafibranor emerged as a potential chemotherapeutic drug for non-muscle invasive bladder cancer

Intravesical infusion of chemotherapeutics is highly recommended by several clinical guidelines for treating nonmuscle invasive bladder cancer (NMIBC). However, cytotoxic chemotherapeutics can cause a series of side effects, which greatly limits their application. Herein, a starvation therapy strate...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Wang Wang, Danni Shan, Guanyi Wang, Xiongmin Mao, Wenjie You, Xiaolong Wang, Zijian Wang
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Elsevier 2024-02-01
Serie:	Cell Insight
Ämnen:	Elafibranor Bladder cancer Conditional reprogramming cell Drug development Preclinical study
Länkar:	http://www.sciencedirect.com/science/article/pii/S277289272400004X
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!